Additionally, oncoprint analysis showed that BRCA1 and BRCA2 mutations, whether germline or somatic, were mutually exclusive in ovarian cancer and breast cancer (Supplementary Fig. 4). This evidence concerns the gene BRCA1 and ovarian carcinoma.